EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Puerarin Reversing Autophagy‐Lysosomal Dysfunction via Acid Sphingomyelinase Inhibition in Cardiomyocytes

Yin-Ping Li iD, Qian He, Xiao-Ying Yu, Sheng-Tao Xiong, Hong-Jing You, Yue Xuan, Wei-Yan Liao, Ze-Yu Chen, Hai-Yan Li, Wei Wang, Yang Chen iD, Xiao Wang

Journal of Cellular and Molecular Medicine · 2025-02 · 29 (4)

DOI: 10.1111/jcmm.70427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 24.02.2025. Verfasst von Yin-Ping Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre of Basic Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, P.R.…. Hauptthemen laut MEDLINE: Autophagy, Myocytes, Cardiac, Lysosomes, Sphingomyelin Phosphodiesterase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Basic Research Program of Guangdong, Guangdong Scientific Research Platform and Projects for the Higher-Educational Institution & Education Science Planning Scheme, Guangdong Basic and Applied Basic Research Natural Science Funding Schemes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is a major cardiovascular disorder characterised by high prevalence and mortality rate. Recent studies have emphasised the role of autophagy in development and progression of HF. Dysfunctions in lysosomes and autophagic processes are closely associated with the aetiology of HF. Puerarin (PUE), a traditional Chinese medicine known for its antioxidant, anti‐inflammatory and antiapoptotic properties, is widely used for the treatment of HF. However, the effectiveness of PUE in HF management via the modulation of autophagy requires further investigation. We used a mouse model of transverse aortic constriction to investigate protective effects of PUE on the autophagy–lysosomal pathway (ALP). We assessed heart function using echocardiography and performed histological staining for fibrosis and hypertrophy. RT‐qPCR for atrial natriuretic peptide (ANP)/brain natriuretic peptide (BNP) and Western blotting for p62/LC3/LAMP1/Beclin1 were performed. Immunofluorescence was used to identify the autophagosomes, autolysosomes and lysosomes. In addition, immunohistochemistry was performed to detect acid sphingomyelinase (ASM) and ceramides. ASM siRNA was transfected into cardiomyocytes to evaluate autophagy. PUE treatment significantly reduced myocardial fibrosis and hypertrophy in HF‐induced mice. PUE also effectively ameliorated ALP impairment in HF‐induced mice and H9c2 cells. Mechanistically, PUE restored lysosomal homeostasis by inhibiting ASM expression and lysosomal transport, thereby enhancing lysosomal activity. These results underscore the therapeutic potential of PUE in correcting the ASM‐mediated disruption of the HF‐linked autophagy–lysosomal pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyMyocytes, CardiacLysosomesSphingomyelin PhosphodiesteraseIsoflavonesHeart FailureAnimalsMiceMaleDisease Models, AnimalMice, Inbred C57BLCell LineFibrosisRats

Stichwörter der Autor:innen

ASMautophagyheart failurelysosomepuerarin

Substanzen

puerarinSphingomyelin PhosphodiesteraseIsoflavones

Autor:innen und Institutionen

  • Research Centre of Basic Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, P.R. China.
  • Department of Pharmacology, School of Pharmaceutical, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

ORCID-Profile: Yin-Ping Li, Yang Chen

Förderung

  • Major Basic Research Program of Guangdong
  • Guangdong Scientific Research Platform and Projects for the Higher-Educational Institution & Education Science Planning Scheme
  • Guangdong Basic and Applied Basic Research Natural Science Funding Schemes
  • National Natural Science Foundation of China
  • Major Program of Science and Technology Program of Guangzhou

Zitieren

APA

Li, Y. P., He, Q., Yu, X. Y., Xiong, S. T., You, H. J., Xuan, Y., Liao, W. Y., Chen, Z. Y., Li, H. Y., Wang, W., Chen, Y., & Wang, X. (2025). Puerarin Reversing Autophagy‐Lysosomal Dysfunction via Acid Sphingomyelinase Inhibition in Cardiomyocytes. Journal of Cellular and Molecular Medicine, 29(4). https://doi.org/10.1111/jcmm.70427

Vancouver

Li YP, He Q, Yu XY, Xiong ST, You HJ, Xuan Y, et al. Puerarin Reversing Autophagy‐Lysosomal Dysfunction via Acid Sphingomyelinase Inhibition in Cardiomyocytes. Journal of Cellular and Molecular Medicine. 2025;29(4). doi:10.1111/jcmm.70427

BibTeX
@article{Li2025,
  author = {Li, Yin-Ping and He, Qian and Yu, Xiao-Ying and Xiong, Sheng-Tao and You, Hong-Jing and Xuan, Yue and Liao, Wei-Yan and Chen, Ze-Yu and Li, Hai-Yan and Wang, Wei and Chen, Yang and Wang, Xiao},
  title = {Puerarin Reversing Autophagy‐Lysosomal Dysfunction via Acid Sphingomyelinase Inhibition in Cardiomyocytes},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  volume = {29},
  number = {4},
  doi = {10.1111/jcmm.70427}
}
Kostenlos starten →